Works matching AU Stadtmauer, Edward A.

Results: 87
    1
    2
    3
    4

    NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.

    Published in:
    Nature Medicine, 2015, v. 21, n. 8, p. 914, doi. 10.1038/nm.3910
    By:
    • Rapoport, Aaron P;
    • Stadtmauer, Edward A;
    • Binder-Scholl, Gwendolyn K;
    • Goloubeva, Olga;
    • Vogl, Dan T;
    • Lacey, Simon F;
    • Badros, Ashraf Z;
    • Garfall, Alfred;
    • Weiss, Brendan;
    • Finklestein, Jeffrey;
    • Kulikovskaya, Irina;
    • Sinha, Sanjoy K;
    • Kronsberg, Shari;
    • Gupta, Minnal;
    • Bond, Sarah;
    • Melchiori, Luca;
    • Brewer, Joanna E;
    • Bennett, Alan D;
    • Gerry, Andrew B;
    • Pumphrey, Nicholas J
    Publication type:
    Article
    5

    Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

    Published in:
    Nature Medicine, 2005, v. 11, n. 11, p. 1230, doi. 10.1038/nm1310
    By:
    • Rapoport, Aaron P.;
    • Stadtmauer, Edward A.;
    • Aqui, Nicole;
    • Badros, Ashraf;
    • Cotte, Julio;
    • Chrisley, Lisa;
    • Veloso, Elizabeth;
    • Zhaohui Zheng;
    • Westphal, Sandra;
    • Mair, Rebecca;
    • Chi, Nina;
    • Ratterree, Bashi;
    • Pochran, Mary Francis;
    • Natt, Sabrina;
    • Hinkle, Joanne;
    • Sickles, Cheryl;
    • Sohal, Ambika;
    • Ruehle, Kathleen;
    • Lynch, Christian;
    • Lei Zhang
    Publication type:
    Article
    6
    7
    8
    9

    Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an eastern cooperative oncology group trial (E4995).

    Published in:
    Leukemia & Lymphoma, 2005, v. 46, n. 1, p. 55, doi. 10.1080/10428190412331283288
    By:
    • Cassileth, Peter;
    • Lee, Sandra;
    • Litzow, Mark;
    • Miller, Kenneth;
    • Stadtmauer, Edward;
    • Tallman, Martin;
    • Lazarus, Hillard;
    • Bennett, John;
    • Paietta, Elisabeth;
    • Dewald, Gordon;
    • Rowe, Jacob
    Publication type:
    Article
    10
    11
    12

    Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?

    Published in:
    British Journal of Haematology, 2022, v. 197, n. 3, p. 326, doi. 10.1111/bjh.18108
    By:
    • Abou‐Ismail, Mouhamed Yazan;
    • Fraser, Raphael;
    • Allbee‐Johnson, Mariam;
    • Metheny, Leland;
    • Ravi, Gayathri;
    • Ahn, Kwang Woo;
    • Bhatt, Neel S.;
    • Lazarus, Hillard M.;
    • de Lima, Marcos;
    • El Jurdy, Najla;
    • Hematti, Peiman;
    • Beitinjaneh, Amer M.;
    • Nishihori, Taiga;
    • Badawy, Sherif M.;
    • Sharma, Akshay;
    • Pasquini, Marcelo C.;
    • Savani, Bipin N.;
    • Sorror, Mohamed L.;
    • Stadtmauer, Edward A.;
    • Chhabra, Saurabh
    Publication type:
    Article
    13

    B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 4, p. 851, doi. 10.1111/bjh.17397
    By:
    • Bernabei, Luca;
    • Tian, Lifeng;
    • Garfall, Alfred L.;
    • Melenhorst, J. Joseph;
    • Lacey, Simon F.;
    • Stadtmauer, Edward A.;
    • Vogl, Dan T.;
    • Gonzalez, Vanessa E.;
    • Plesa, Gabriela;
    • Young, Regina M.;
    • Waxman, Adam;
    • Levine, Bruce L.;
    • June, Carl H.;
    • Milone, Michael C.;
    • Cohen, Adam D.
    Publication type:
    Article
    14
    15
    16

    Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.

    Published in:
    Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 892, doi. 10.1177/10781552221080710
    By:
    • Hatch, Rachel V.;
    • Freyer, Craig W.;
    • Carulli, Alison;
    • Redline, Gretchen;
    • Babushok, Daria V.;
    • Frey, Noelle V.;
    • Gill, Saar I.;
    • Hexner, Elizabeth O.;
    • Luger, Selina M.;
    • Martin, Mary Ellen;
    • McCurdy, Shannon R.;
    • Perl, Alexander E.;
    • Porter, David L.;
    • Pratz, Keith W.;
    • Stadtmauer, Edward A.;
    • Loren, Alison W.
    Publication type:
    Article
    17

    OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
    By:
    • Lonial, Sagar;
    • Richardson, Paul G.;
    • Popat, Rakesh;
    • Stadtmauer, Edward A.;
    • Larsen, Jeremy T.;
    • Oriol, A.;
    • Knop, Stefan;
    • Jagannath, Sundar;
    • Cook, Gordon;
    • Badros, Ashraf Z.;
    • Rodríguez-Otero, Paula;
    • Siegel, David S.;
    • Tuong Vi Nguyen;
    • Micco, Antonia Di;
    • Amin, Alpesh;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    18
    19
    20
    21

    Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.250
    By:
    • Qazilbash, Muzaffar;
    • Stadtmauer, Edward;
    • Baladandayuthapani, Veera;
    • Tross, Beryl;
    • Honhar, Medhavi;
    • Cha, Soung-chul;
    • Kim, Kunhwa;
    • Rao, Sheeta;
    • Popescu, Michael;
    • Shah, Nina;
    • Bashir, Qaiser;
    • Patel, Krina;
    • Shpall, Elizabeth;
    • Weber, Donna;
    • Thomas, Sheeba;
    • Shah, Jatin;
    • Orlowski, Robert;
    • Kerr, Naseem;
    • Garfall, Alfred;
    • Cohen, Adam
    Publication type:
    Article
    22

    Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment Crossover in the CALGB/ECOG 100104 (Alliance) Study of Lenalidomide (LEN) Versus Placebo (PBO) Maintenance After Stem Cell Transplant (SCT) for Patients With Newly Diagnosed Multiple Myeloma

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e135, doi. 10.1016/j.clml.2017.03.244
    By:
    • McCarthy, Philip;
    • Holstein, Sarah;
    • Jung, Sin-Ho;
    • Cooper, Miranda;
    • Gibson, Craig J.;
    • Stadtmauer, Edward;
    • Winograd, Benjamin;
    • Richardson, Paul
    Publication type:
    Article
    23
    24

    Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.

    Published in:
    2014
    By:
    • Raje, Noopur;
    • Faiman, Beth;
    • Harvey, R. Donald;
    • Kurtin, Sandra E.;
    • Lonial, Sagar;
    • Kumar, Shaji K.;
    • Cohen, Adam D.;
    • Conde, Miguel A.;
    • Giralt, Sergio A.;
    • Recine, Marie Sabo;
    • Tombler, Eugene R.;
    • Stadtmauer, Edward;
    • Jagannath, Sundar;
    • Anderson, Kenneth C.;
    • Managing Myeloma Continuing Education Initiative Advisory Group
    Publication type:
    journal article
    25
    26

    Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 38, doi. 10.3816/CLML.2010.n.120
    By:
    • San-Miguel, Jesús F.;
    • Dimopoulos, Meletios A.;
    • Stadtmauer, Edward A.;
    • Rajkumar, S. Vincent;
    • Siegel, David;
    • Bravo, Marie-Laure;
    • Olesnyckyj, Marta;
    • Knight, Robert D.;
    • Zeldis, Jerome B.;
    • Harousseau, Jean-Luc;
    • Weber, Donna M.
    Publication type:
    Article
    27

    Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.

    Published in:
    Clinical Infectious Diseases, 2019, v. 68, n. 12, p. 2003, doi. 10.1093/cid/ciy822
    By:
    • Ganetsky, Alex;
    • Han, Jennifer H;
    • Hughes, Mitchell E;
    • Babushok, Daria V;
    • Frey, Noelle V;
    • Gill, Saar I;
    • Hexner, Elizabeth O;
    • Loren, Alison W;
    • Luger, Selina M;
    • Mangan, James K;
    • Martin, Mary Ellen;
    • Smith, Jacqueline;
    • Freyer, Craig W;
    • Gilmar, Cheryl;
    • Schuster, Mindy;
    • Stadtmauer, Edward A;
    • Porter, David L
    Publication type:
    Article
    28

    Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.

    Published in:
    2005
    By:
    • Larson, Richard A;
    • Sievers, Eric L;
    • Stadtmauer, Edward A;
    • Löwenberg, Bob;
    • Estey, Elihu H;
    • Dombret, Hervé;
    • Theobald, Matthias;
    • Voliotis, Dimitris;
    • Bennett, John M;
    • Richie, Maria;
    • Leopold, Lance H;
    • Berger, Mark S;
    • Sherman, Matthew L;
    • Loken, Michael R;
    • van Dongen, Jacques J M;
    • Bernstein, Irwin D;
    • Appelbaum, Frederick R
    Publication type:
    journal article
    29

    Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1442, doi. 10.1002/cncr.21326
    By:
    • Richard A. Larson;
    • Eric L. Sievers;
    • Edward A. Stadtmauer;
    • Bob Löwenberg;
    • Elihu H. Estey;
    • Hervé Dombret;
    • Matthias Theobald;
    • Dimitris Voliotis;
    • John M. Bennett;
    • Maria Richie;
    • Lance H. Leopold;
    • Mark S. Berger;
    • Matthew L. Sherman;
    • Michael R. Loken;
    • Jacques J. M. van Dongen;
    • Irwin D. Bernstein;
    • Frederick R. Appelbaum
    Publication type:
    Article
    30
    31
    32
    33

    Danazol treatment of myelodysplastic syndromes.

    Published in:
    British Journal of Haematology, 1991, v. 77, n. 4, p. 502, doi. 10.1111/j.1365-2141.1991.tb08617.x
    By:
    • Stadtmauer, Edward A.;
    • Cassileth, Peter A.;
    • Edelstein, Marian;
    • Abrahm, Janet;
    • Schreiber, Alan D.;
    • Nowell, Peter C.;
    • Cines, Douglas B.
    Publication type:
    Article
    34
    35
    36
    37

    B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma.

    Published in:
    2019
    By:
    • Cohen, Adam D.;
    • Garfall, Alfred L.;
    • Stadtmauer, Edward A.;
    • Melenhorst, J. Joseph;
    • Lacey, Simon F.;
    • Lancaster, Eric;
    • Vogl, Dan T.;
    • Weiss, Brendan M.;
    • Dengel, Karen;
    • Nelson, Annemarie;
    • Plesa, Gabriela;
    • Fang Chen;
    • Davis, Megan M.;
    • Wei-Ting Hwang;
    • Young, Regina M.;
    • Brogdon, Jennifer L.;
    • Isaacs, Randi;
    • Pruteanu-Malinici, Iulian;
    • Siegel, Don L.;
    • Levine, Bruce L.
    Publication type:
    journal article
    38

    Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.

    Published in:
    1999
    By:
    • Rowlings, Philip A.;
    • Williams, Stephanie F.;
    • Antman, Karen H.;
    • Fields, Karen K.;
    • Fay, Joseph W.;
    • Reed, Elizabeth;
    • Pelz, Corey J.;
    • Klein, John P.;
    • Sobocinski, Kathleen A.;
    • Kennedy, M. John;
    • Freytes, Cesar O.;
    • McCarthy Jr., Philip L.;
    • Herzig, Roger H.;
    • Stadtmauer, Edward A.;
    • Lazarus, Hillard M.;
    • Pecora, Andrew L.;
    • Bitran, Jacob D.;
    • Wolff, Steven N.;
    • Gale, Robert Peter;
    • Armitage, James O.
    Publication type:
    journal article
    39

    Combined autophagy and proteasome inhibition.

    Published in:
    Autophagy, 2014, v. 10, n. 8, p. 1380, doi. 10.4161/auto.29264
    By:
    • Vogl, Dan T.;
    • Stadtmauer, Edward A.;
    • Kay-See Tan;
    • Heitjan, Daniel F.;
    • Davis, Lisa E.;
    • Pontiggia, Laura;
    • Rangwala, Reshma;
    • Shengfu Piao;
    • Yunyoung C. Chang;
    • Scott, Emma C.;
    • Paul, Thomas M.;
    • Nichols, Charles W.;
    • Porter, David L.;
    • Kaplan, Janeen;
    • Mallon, Gayle;
    • Bradner, James E.;
    • Amaravadi, Ravi K.
    Publication type:
    Article
    40

    Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 5, p. 816, doi. 10.1111/bjh.14170
    By:
    • D'Souza, Anita;
    • Pasquini, Marcelo;
    • Logan, Brent;
    • Giralt, Sergio;
    • Krishnan, Amrita;
    • Antin, Joseph;
    • Howard, Alan;
    • Goodman, Stacy;
    • Qazilbash, Muzzafar;
    • Knust, Kristin;
    • Sahebi, Firoozeh;
    • Weisdorf, Daniel;
    • Vesole, David;
    • Stadtmauer, Edward;
    • Maloney, David;
    • Hari, Parameswaran
    Publication type:
    Article
    41
    42
    43
    44

    Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.

    Published in:
    British Journal of Haematology, 2009, v. 146, n. 2, p. 164, doi. 10.1111/j.1365-2141.2009.07728.x
    By:
    • Chen, Christine;
    • Reece, Donna E.;
    • Siegel, David;
    • Niesvizky, Ruben;
    • Boccia, Ralph V.;
    • Stadtmauer, Edward A.;
    • Abonour, Rafat;
    • Richardson, Paul;
    • Matous, Jeffrey;
    • Kumar, Shaji;
    • Bahlis, Nizar J.;
    • Alsina, Melissa;
    • Vescio, Robert;
    • Coutre, Steven E.;
    • Pietronigro, Dennis;
    • Knight, Robert D.;
    • Zeldis, Jerome B.;
    • Rajkumar, Vincent
    Publication type:
    Article
    45

    Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.

    Published in:
    British Journal of Haematology, 2009, v. 144, n. 6, p. 895, doi. 10.1111/j.1365-2141.2008.07573.x
    By:
    • Richardson, Paul G.;
    • Sonneveld, Pieter;
    • Schuster, Michael W.;
    • Stadtmauer, Edward A.;
    • Facon, Thierry;
    • Harousseau, Jean-Luc;
    • Ben-Yehuda, Dina;
    • Lonial, Sagar;
    • Goldschmidt, Hartmut;
    • Reece, Donna;
    • Blad, Joan;
    • Boccadoro, Mario;
    • Cavenagh, Jamie D.;
    • Boral, Anthony L.;
    • Esseltine, Dixie-Lee;
    • Wen, Patrick Y.;
    • Amato, Anthony A.;
    • Anderson, Kenneth C.;
    • San Miguel, Jesus
    Publication type:
    Article
    46

    Radioimmunotherapy of Non-Hodgkin's Lymphoma with <sup>90</sup>Y-DOTA Humanized Anti-CD22 IgG (<sup>90</sup>Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?

    Published in:
    Journal of Nuclear Medicine, 2003, v. 44, n. 12, p. 2000
    By:
    • Sharkey, Robert M.;
    • Brenner, Arnold;
    • Burton, Jack;
    • Hajjar, George;
    • Toder, Stephen P.;
    • Alavi, Abass;
    • Matthies, Alexander;
    • Tsai, Donald E.;
    • Schuster, Stephen J.;
    • Stadtmauer, Edward A.;
    • Czuczman, Myron S.;
    • Lamonica, Dominick;
    • Kraeber-Bodere, Françoise;
    • Mahe, Beatrice;
    • Chatal, Jean-François;
    • Rogatko, André;
    • Mardirrosian, George;
    • Goldenberg, David M.
    Publication type:
    Article
    47

    Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.

    Published in:
    Human Vaccines & Immunotherapeutics, 2021, v. 17, n. 11, p. 4144, doi. 10.1080/21645515.2021.1953346
    By:
    • Stadtmauer, Edward A.;
    • Sullivan, Keith M.;
    • El Idrissi, Mohamed;
    • Salaun, Bruno;
    • Alonso Alonso, Aránzazu;
    • Andreadis, Charalambos;
    • Anttila, Veli-Jukka;
    • Bloor, Adrian JC;
    • Broady, Raewyn;
    • Cellini, Claudia;
    • Cuneo, Antonio;
    • Dagnew, Alemnew F.;
    • Di Paolo, Emmanuel;
    • Eom, HyeonSeok;
    • González-Rodríguez, Ana Pilar;
    • Grigg, Andrew;
    • Guenther, Andreas;
    • Heineman, Thomas C.;
    • Jarque, Isidro;
    • Kwak, Jae-Yong
    Publication type:
    Article
    48
    49

    Progressive multifocal leukoencephalopathy in multiple myeloma.

    Published in:
    European Journal of Haematology, 2023, v. 110, n. 3, p. 322, doi. 10.1111/ejh.13909
    By:
    • Hoeynck, Brian W.;
    • Cohen, Adam D.;
    • Stadtmauer, Edward A.;
    • Susanibar‐Adaniya, Sandra P.;
    • Vogl, Dan T.;
    • Waxman, Adam J.;
    • Bardsley, Mark;
    • Le, Samantha;
    • LaMaestra, Lexis;
    • Garfall, Alfred L.
    Publication type:
    Article
    50

    Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.

    Published in:
    European Journal of Haematology, 2009, v. 82, n. 6, p. 426, doi. 10.1111/j.1600-0609.2009.01257.x
    By:
    • Stadtmauer, Edward A.;
    • Weber, Donna M.;
    • Niesvizky, Ruben;
    • Belch, Andrew;
    • Prince, Miles H.;
    • San Miguel, Jesús F.;
    • Facon, Thierry;
    • Olesnyckyj, Marta;
    • Yu, Zhinuan;
    • Zeldis, Jerome B.;
    • Knight, Robert D.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article